A Double-Blind, Randomized Comparison of Levofloxacin 750 mg Once-Daily for Five Days With Ciprofloxacin 400/500 mg Twice-Daily for 10 Days for the Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis
- 1 January 2008
- journal article
- research article
- Published by Elsevier BV in Urology
- Vol. 71 (1), 17-22
- https://doi.org/10.1016/j.urology.2007.09.002
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Concentrations in plasma, urinary excretion and bactericidal activity of levofloxacin (500mg) versus ciprofloxacin (500mg) in healthy volunteers receiving a single oral doseInternational Journal of Antimicrobial Agents, 2006
- Comparison of the adverse event profiles of levofloxacin 500 mg and 750 mg in clinical trials for the treatment of respiratory infectionsCurrent Medical Research and Opinion, 2006
- Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA)International Journal of Antimicrobial Agents, 2006
- The current management strategies for community-acquired urinary tract infectionInfectious Disease Clinics of North America, 2003
- Pharmacodynamics of 750 mg and 500 mg doses of levofloxacin against ciprofloxacin-resistant strains of Streptococcus pneumoniaeDiagnostic Microbiology and Infectious Disease, 2002
- Urinary Tract Pathogens in Complicated Infection and in Elderly IndividualsThe Journal of Infectious Diseases, 2001
- Comparison of Ciprofloxacin (7 Days) and Trimethoprim-Sulfamethoxazole (14 Days) for Acute Uncomplicated Pyelonephritis in WomenJAMA, 2000
- Guidelines for Antimicrobial Treatment of Uncomplicated Acute Bacterial Cystitis and Acute Pyelonephritis in WomenClinical Infectious Diseases, 1999
- Testing for Qualitative Interactions between Treatment Effects and Patient SubsetsBiometrics, 1985